BRL 5.66
(5.01%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 524.39 Million | 296.29 Million | 338.59 Million | 277.93 Million | 255.34 Million | 357.96 Million |
Net Income | -8.02 Million | 6.34 Million | 4.98 Million | 189.35 Million | -192.62 Million | -364.51 Million |
Depreciation & Amortization | 180.1 Million | 176.59 Million | 401.64 Million | 423.72 Million | 408.22 Million | 280.69 Million |
Deferred income taxes | -95.86 Million | 87.5 Million | -47.9 Million | 35.74 Million | -114.16 Million | -58.24 Million |
Stock-based compensation | - | - | - | - | - | -7.27 Million |
Change in working capital | 360.8 Million | 220.61 Million | -65.55 Million | -83.14 Million | 6.12 Million | -168.76 Million |
Other non-cash items | 438.25 Million | -107.25 Million | -2.47 Million | -251.99 Million | 33.61 Million | 610.54 Million |
Investing Cash Flow | -286.89 Million | -130.61 Million | -130.28 Million | -93.92 Million | 1.8 Million | -42.61 Million |
Investments in PPE | -286.89 Million | -166.03 Million | -171.22 Million | -120.35 Million | -40.91 Million | -164.17 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | 800 Thousand | - | - | 121.56 Million |
Other Investing Activities | -237.43 Million | 35.41 Million | 40.13 Million | 26.43 Million | 42.71 Million | -34.66 Million |
Financing Cash Flow | -244.2 Million | -179.88 Million | -190.64 Million | -231.57 Million | -257.03 Million | -571.91 Million |
Debt repayment | -236.26 Million | -423.96 Million | -284.81 Million | -212.26 Million | -229.74 Million | -376.78 Million |
Dividends payments | -7.94 Million | -3.24 Million | -7.15 Million | - | - | -80.2 Million |
Common Stock Repurchased | - | - | - | - | - | -84.74 Million |
Common Stock Issuance | - | - | - | - | 1.06 Million | 1.59 Million |
Other Financing Activities | -4.91 Million | 247.32 Million | 101.32 Million | -19.31 Million | -28.35 Million | -31.77 Million |
Accounts receivables | -10.57 Million | -8.74 Million | 15.86 Million | -126.76 Million | -49.75 Million | 6.86 Million |
Accounts payables | 19.9 Million | 16.24 Million | 21.58 Million | -11 Million | -23.86 Million | -20.71 Million |
Inventory | - | 297.56 Million | -4.6 Million | 3.97 Million | 21.41 Million | - |
Other working capital | 351.47 Million | -84.44 Million | -98.39 Million | 50.64 Million | 58.33 Million | 152.72 Million |
Cash at beginning of period | 64.89 Million | 71.78 Million | 54.11 Million | 101.67 Million | 119.56 Million | 376.13 Million |
Cash at end of period | 59.17 Million | 57.58 Million | 71.78 Million | 54.11 Million | 101.67 Million | 119.56 Million |
Capital Expenditure | -286.89 Million | -166.03 Million | -171.22 Million | -120.35 Million | -40.91 Million | -164.17 Million |
Effect of forex changes on cash | 994 Thousand | - | - | - | -18 Million | - |
Net cash flow / Change in cash | -5.71 Million | -14.2 Million | 17.67 Million | -47.55 Million | -17.89 Million | -256.56 Million |
Free Cash Flow | 237.49 Million | 130.26 Million | 167.37 Million | 157.57 Million | 214.43 Million | 193.78 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 25.99 Million | 5.09 Million | 39.25 Million | -8.02 Million | 96.03 Million | -65.56 Million |
Depreciation & Amortization | 47.3 Million | 43.93 Million | 54.09 Million | 180.1 Million | 46.27 Million | 40.97 Million |
Deferred income taxes | - | -3.06 Million | -3.4 Million | -95.86 Million | -73.1 Million | -8.76 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 55.58 Million | -27.38 Million | 306.47 Million | 360.8 Million | 50.25 Million | -88.94 Million |
Other non-cash items | 99.12 Million | 175.29 Million | -96.04 Million | 438.25 Million | -24.04 Million | 191.43 Million |
Investing Cash Flow | -78.62 Million | -26.33 Million | -101.15 Million | -286.89 Million | -105.36 Million | -22.23 Million |
Investments in PPE | -78.62 Million | -26.33 Million | -101.15 Million | -286.89 Million | -115.38 Million | -42.17 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -59.67 Million | -19.83 Million | -90.63 Million | -237.43 Million | 10.02 Million | 19.93 Million |
Financing Cash Flow | -66.41 Million | -79.29 Million | -57.88 Million | -244.2 Million | -71.93 Million | -57.88 Million |
Debt repayment | -66.41 Million | -79.29 Million | -49.94 Million | -236.26 Million | -72.07 Million | -55.23 Million |
Dividends payments | - | - | -7.94 Million | -7.94 Million | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -924 Thousand | -4.91 Million | 146 Thousand | -2.65 Million |
Accounts receivables | -616 Thousand | -25.24 Million | 5.21 Million | -10.57 Million | 7.59 Million | -4.99 Million |
Accounts payables | 25.89 Million | 14.67 Million | -20.75 Million | 19.9 Million | 16.61 Million | 9.4 Million |
Inventory | - | - | - | - | - | - |
Other working capital | 30.31 Million | -16.8 Million | 322.01 Million | 351.47 Million | 26.04 Million | -93.35 Million |
Cash at beginning of period | 48.58 Million | 59.17 Million | 41.71 Million | 64.89 Million | 42.04 Million | 44.26 Million |
Cash at end of period | 62.98 Million | 48.58 Million | 59.17 Million | 59.17 Million | 33.26 Million | 42.04 Million |
Capital Expenditure | -78.62 Million | -26.33 Million | -101.15 Million | -286.89 Million | -115.38 Million | -42.17 Million |
Effect of forex changes on cash | - | - | -140 Thousand | 994 Thousand | - | - |
Net cash flow / Change in cash | 14.39 Million | -10.58 Million | 17.46 Million | -5.71 Million | -8.78 Million | -2.21 Million |
Free Cash Flow | 80.03 Million | 69.09 Million | 75.48 Million | 237.49 Million | 53.13 Million | 35.73 Million |
MBIN
AMRUTANJAN
SGF
ESRCF
FRFHF
600617